Progesterone receptor isoform expression in human meningiomas

Area of Science:

• Neuro-oncology
• Endocrinology
• Molecular Biology

Background:

• Meningiomas are typically progesterone-responsive due to progesterone receptor (PR) expression.
• PR isoforms, PR-A and PR-B, have distinct biological functions.
• Understanding differential PR isoform expression is crucial for meningioma growth and treatment.

Purpose of the Study:

• To quantify the expression levels of PR-A and PR-B isoforms in human meningiomas.
• To investigate the relationship between PR isoform ratios and total PR levels.
• To explore the potential biological and clinical significance of PR isoform variability.

Main Methods:

• Immunoblotting was used to determine PR-A and PR-B expression in 61 human meningiomas.
• Ligand binding assay (LBA) measured total PR levels (total PR(LBA)).

Main Results:

• Both PR-A and PR-B isoforms, along with a 78 kDa PR variant (PR-78), were detected in meningiomas.
• Higher PR-A to PR-B ratios correlated with significantly higher total PR(LBA) levels (P<0.001).
• PR-78 expression was inversely associated with PR-B levels (r(s)=-0.76, P<0.0001), suggesting a potential degradation product or co-regulated protein.

Conclusions:

• Human meningiomas exhibit variable ratios of PR-A and PR-B isoforms.
• The predominance of PR-A over PR-B in most meningiomas suggests progesterone action may involve transrepression rather than transactivation.
• Progesterone blockade efficacy may be limited to specific meningioma subsets with particular PR isoform profiles.